Back to search
FDAFDA · Food and drugs·Recall number D-0304-2020

Cephalexin for Oral Suspension USP, 250 mg/5mL, 200 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mumbai 400 098 INDIA, NDC 68180-0441-02

Published November 13, 2019 · Recall initiated: November 1, 2019

Summary

FDA records drug Class III recall D-0304-2020, published November 13, 2019 and initiated November 1, 2019. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 28,254 bottles; Lot: Lot #: F802436, F802437, F802438, F802442, Exp 11/20. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign substance: identified as a dead ant.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
Product was distributed to major distributors/wholesalers throughout the United States.
Lot
Lot #: F802436, F802437, F802438, F802442, Exp 11/20
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cephalexin for Oral Suspension USP, 250 mg/5mL, 200 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mumbai 400 098 INDIA, NDC 68180-0441-02 recalled?

Yes. FDA published recall D-0304-2020 on November 13, 2019. Reported hazard: Presence of Foreign substance: identified as a dead ant.

What should I do if I have this product?

Voluntary: Firm initiated · Letter